Literature DB >> 14580962

Drugs for the control of parasitic diseases: current status and development in schistosomiasis.

Alan Fenwick1, Lorenzo Savioli, Dirk Engels, N Robert Bergquist, Matthew H Todd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14580962     DOI： 10.1016/j.pt.2003.09.005

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


× No keyword cloud information.
  87 in total

Review 1.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

2.  Environmental effects on parasitic disease transmission exemplified by schistosomiasis in western China.

Authors:  Song Liang; Edmund Y W Seto; Justin V Remais; Bo Zhong; Changhong Yang; Alan Hubbard; George M Davis; Xueguang Gu; Dongchuan Qiu; Robert C Spear
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

3.  Profiling Schistosoma mansoni development using serial analysis of gene expression (SAGE).

Authors:  David L Williams; Ahmed A Sayed; Jeremiah Bernier; Shanda R Birkeland; Michael J Cipriano; Alexandria R Papa; Andrew G McArthur; Andrew Taft; Jon J Vermeire; Timothy P Yoshino
Journal:  Exp Parasitol       Date:  2007-05-13       Impact factor: 2.011

Review 4.  Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.

Authors:  Eleanor A Ochodo; Gowri Gopalakrishna; Bea Spek; Johannes B Reitsma; Lisette van Lieshout; Katja Polman; Poppy Lamberton; Patrick M M Bossuyt; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-03-11

5.  Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution.

Authors:  J Utzinger; G Raso; S Brooker; D De Savigny; M Tanner; N Ornbjerg; B H Singer; E K N'goran
Journal:  Parasitology       Date:  2009-11       Impact factor: 3.234

Review 6.  Urinary schistosomiasis.

Authors:  Oluwatoyin F Bamgbola
Journal:  Pediatr Nephrol       Date:  2014-01-28       Impact factor: 3.714

7.  Health seeking behaviour and utilization of health facilities for schistosomiasis-related symptoms in ghana.

Authors:  Anthony Danso-Appiah; Wilma A Stolk; Kwabena M Bosompem; Joseph Otchere; Caspar W N Looman; J Dik F Habbema; Sake J de Vlas
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

8.  Development and validation of a quantitative, high-throughput, fluorescent-based bioassay to detect schistosoma viability.

Authors:  Emily Peak; Iain W Chalmers; Karl F Hoffmann
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

9.  Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

Authors:  Sandra D Melman; Michelle L Steinauer; Charles Cunningham; Laura S Kubatko; Ibrahim N Mwangi; Nirvana Barker Wynn; Martin W Mutuku; Diana M S Karanja; Daniel G Colley; Carla L Black; William Evan Secor; Gerald M Mkoji; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18

10.  Anti-schistosomal intervention targets identified by lifecycle transcriptomic analyses.

Authors:  Jennifer M Fitzpatrick; Emily Peak; Samirah Perally; Iain W Chalmers; John Barrett; Timothy P Yoshino; Alasdair C Ivens; Karl F Hoffmann
Journal:  PLoS Negl Trop Dis       Date:  2009-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.